TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Surgical Science Sweden AB
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
894,358
|
759,133
|
357,690 |
Financial expenses |
665
|
18,430
|
22,378 |
Earnings before taxes |
271,760
|
196,913
|
64,174 |
EBITDA |
247,955
|
172,337
|
75,795 |
Total assets |
4,763,957
|
4,398,081
|
3,879,564 |
Current assets |
1,004,109
|
781,675
|
601,623 |
Current liabilities |
237,999
|
289,362
|
226,619 |
Equity capital |
4,401,838
|
4,007,313
|
3,496,244 |
- share capital |
2,584
|
2,403
|
2,477 |
Employees (average) |
249
|
227
|
121 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
92.4%
|
91.1%
|
90.1% |
Turnover per employee |
3,592
|
3,344
|
2,956 |
Profit as a percentage of turnover |
30.4%
|
25.9%
|
17.9% |
Return on assets (ROA) |
5.7%
|
4.9%
|
2.2% |
Current ratio |
421.9%
|
270.1%
|
265.5% |
Return on equity (ROE) |
6.2%
|
4.9%
|
1.8% |
Change turnover |
81,360
|
412,193
|
255,488 |
Change turnover % |
10%
|
119%
|
250% |
Chg. No. of employees |
22
|
106
|
64 |
Chg. No. of employees % |
10%
|
88%
|
112% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.